Oral mucormycosis in post-COVID-19 patients: A case series
Oral Dis
.
2022 Nov:28 Suppl 2:2591-2592.
doi: 10.1111/odi.13973.
Epub 2021 Aug 20.
Authors
Enji Ahmed
1
2
,
Asmaa Abou-Bakr
2
,
Radwa R Hussein
3
,
Ayman A El-Gawish
2
,
Abou-Bakr E Ras
4
,
Dalia M Ghalwash
2
Affiliations
1
Department of Oral Medicine and Periodontology, Faculty of Dentistry, Cairo University, Giza, Egypt.
2
Department of Oral Medicine and Periodontology, Faculty of Dentistry, The British University in Egypt, El Sherouk City, Egypt.
3
Department of Oral Medicine and Periodontology, Faculty of Dentistry, Ain Shams University, Cairo, Egypt.
4
Otolaryngology Department, Faculty of Medicine, Benha University, Qalyoubya, Egypt.
PMID:
34289206
PMCID:
PMC8447017
DOI:
10.1111/odi.13973
No abstract available
Keywords:
Fistula; mucormycosis; oral; palate; post-COVID-19; ulcer.
Publication types
Letter
MeSH terms
Antifungal Agents / therapeutic use
COVID-19* / complications
Humans
Mucormycosis* / complications
Mucormycosis* / drug therapy
Substances
Antifungal Agents